Machiels Alec

Insider CIK 1496687 · CREX Director · APLS Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	121,894	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	17,580	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	5,748	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	14,684	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	27,600	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	11,199	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	8,554	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	7,441	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer deriv	2026-05-14	2026-05-14	27,600	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	150,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	7,961	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	5,744	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	3,062	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	D To issuer	2026-05-14	2026-05-14	3,544	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	11,950	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	250,000	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	U Tender	2026-05-14	2026-05-14	384,989	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2026-01-01	2026-01-05	14,684	—	$0	14,684	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2026-01-01	2026-01-05	7,961	—	$0	384,989	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2025-01-01	2025-01-03	11,199	—	$0	11,199	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2025-01-01	2025-01-03	6,267	—	$0	377,028	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2024-01-01	2024-01-02	5,748	$59.86	$344.1K	5,748	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2024-01-01	2024-01-02	3,341	—	$0	370,761	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-11-17	2023-11-20	1,250	—	$0	0	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-11-17	2023-11-20	1,250	$47.74	$59.7K	367,420	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-11-17	2023-11-20	1,250	$2.67	$3.3K	368,670	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-10-17	2023-10-18	1,250	—	$0	1,250	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-10-17	2023-10-18	1,250	$2.67	$3.3K	368,670	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-10-17	2023-10-18	1,250	$48.50	$60.6K	367,420	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-09-18	2023-09-19	1,250	—	$0	2,500	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-09-18	2023-09-19	1,250	$45.00	$56.3K	367,420	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-09-18	2023-09-19	1,250	$2.67	$3.3K	368,670	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-09-15	2023-09-18	1,250	—	$0	3,750	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-09-15	2023-09-18	1,250	$2.67	$3.3K	368,670	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-09-15	2023-09-18	1,250	$45.34	$56.7K	367,420	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-07-21	2023-07-24	49,779	—	$0	5,000	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-07-21	2023-07-24	49,779	$2.67	$132.9K	367,420	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-07-20	2023-07-21	50,000	—	$0	54,779	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-07-20	2023-07-21	50,000	$2.67	$133.5K	317,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-07-17	2023-07-18	1,250	—	$0	104,779	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-07-17	2023-07-18	1,250	$64.79	$81.0K	267,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-07-17	2023-07-18	1,250	$2.67	$3.3K	268,891	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-06-20	2023-06-21	1,250	—	$0	106,029	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-06-20	2023-06-21	1,250	$2.67	$3.3K	268,891	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-06-20	2023-06-21	1,250	$88.41	$110.5K	267,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-05-17	2023-05-18	1,250	—	$0	107,279	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-05-17	2023-05-18	1,250	$88.66	$110.8K	267,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-05-17	2023-05-18	1,250	$2.67	$3.3K	268,891	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-04-17	2023-04-18	1,250	—	$0	108,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-04-17	2023-04-18	1,250	$2.67	$3.3K	268,891	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-04-17	2023-04-18	1,250	$81.05	$101.3K	267,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-03-17	2023-03-21	1,250	—	$0	109,779	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-03-17	2023-03-21	1,250	$2.67	$3.3K	268,891	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-03-17	2023-03-21	1,250	$64.03	$80.0K	267,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-02-17	2023-02-21	1,250	—	$0	111,029	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-02-17	2023-02-21	1,250	$2.67	$3.3K	268,891	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-02-17	2023-02-21	1,250	$52.38	$65.5K	267,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2023-01-17	2023-01-19	1,250	—	$0	112,279	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2023-01-17	2023-01-19	1,250	$52.42	$65.5K	267,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2023-01-17	2023-01-19	1,250	$2.67	$3.3K	268,891	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2023-01-01	2023-01-04	7,441	—	$0	7,441	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2023-01-01	2023-01-04	3,867	—	$0	267,641	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-12-15	2022-12-19	1,250	—	$0	113,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-12-15	2022-12-19	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-12-15	2022-12-19	1,250	$52.35	$65.4K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-11-15	2022-11-17	1,250	—	$0	114,779	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-11-15	2022-11-17	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-11-15	2022-11-17	1,250	$48.01	$60.0K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-10-14	2022-10-17	1,250	—	$0	116,029	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-10-14	2022-10-17	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-10-14	2022-10-17	1,250	$59.31	$74.1K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-09-15	2022-09-16	1,250	—	$0	117,279	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-09-15	2022-09-16	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-09-15	2022-09-16	1,250	$66.00	$82.5K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-08-15	2022-08-16	1,250	—	$0	118,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-08-15	2022-08-16	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-08-15	2022-08-16	1,250	$67.21	$84.0K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-07-15	2022-07-18	1,250	—	$0	119,779	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-07-15	2022-07-18	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-07-15	2022-07-18	1,250	$46.33	$57.9K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-06-15	2022-06-17	1,250	—	$0	121,029	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-06-15	2022-06-17	1,250	$39.29	$49.1K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-06-15	2022-06-17	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-05-16	2022-05-17	1,250	—	$0	122,279	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-05-16	2022-05-17	1,250	$39.18	$49.0K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-05-16	2022-05-17	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-04-14	2022-04-18	1,250	—	$0	123,529	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-04-14	2022-04-18	1,250	$50.90	$63.6K	263,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-04-14	2022-04-18	1,250	$2.67	$3.3K	265,024	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-03-15	2022-03-17	1,250	—	$0	124,779	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-03-15	2022-03-17	1,250	$2.67	$3.3K	260,794	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-03-15	2022-03-17	1,250	$39.57	$49.5K	259,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-02-15	2022-02-16	1,250	—	$0	126,029	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-02-15	2022-02-16	1,250	$45.43	$56.8K	673,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-02-15	2022-02-16	1,250	$2.67	$3.3K	675,024	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2022-01-14	2022-01-19	1,250	—	$0	27,279	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2022-01-14	2022-01-19	1,250	$40.56	$50.7K	673,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2022-01-14	2022-01-19	1,250	$2.67	$3.3K	675,024	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2022-01-01	2022-01-04	8,554	—	$0	8,554	SEC↗
APLS Apellis Pharmaceuticals, I	A Award	2022-01-01	2022-01-04	4,230	—	$0	673,774	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-12-15	2021-12-17	3,000	—	$0	128,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-12-15	2021-12-17	3,000	$2.67	$8.0K	672,544	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-12-15	2021-12-17	3,000	$42.88	$128.6K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-11-15	2021-11-17	3,000	—	$0	131,529	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-11-15	2021-11-17	3,000	$43.50	$130.5K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-11-15	2021-11-17	3,000	$2.67	$8.0K	672,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-11-04	2021-11-17	3,000	—	$0	134,529	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-11-04	2021-11-17	3,000	$35.00	$105.0K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-11-04	2021-11-17	3,000	$2.67	$8.0K	672,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-08-16	2021-08-17	2,500	—	$0	137,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-08-16	2021-08-17	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-08-16	2021-08-17	2,500	$56.95	$142.4K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-07-15	2021-07-16	2,500	—	$0	140,029	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-07-15	2021-07-16	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-07-15	2021-07-16	2,500	$62.30	$155.8K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-06-15	2021-06-16	2,500	—	$0	142,529	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-06-15	2021-06-16	2,500	$64.83	$162.1K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-06-15	2021-06-16	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-05-14	2021-05-18	2,500	—	$0	145,029	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-05-14	2021-05-18	2,500	$45.39	$113.5K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-05-14	2021-05-18	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-04-21	2021-04-22	2,500	—	$0	147,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-04-21	2021-04-22	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-04-21	2021-04-22	2,500	$45.76	$114.4K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-03-15	2021-03-17	2,500	—	$0	150,029	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-03-15	2021-03-17	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-03-15	2021-03-17	2,500	$46.77	$116.9K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-02-16	2021-02-17	2,500	—	$0	152,529	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-02-16	2021-02-17	2,500	$46.00	$115.0K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-02-16	2021-02-17	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2021-01-15	2021-01-19	2,500	—	$0	155,029	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2021-01-15	2021-01-19	2,500	$53.15	$132.9K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2021-01-15	2021-01-19	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2021-01-01	2021-01-04	27,600	—	$0	27,600	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-12-15	2020-12-16	2,500	—	$0	157,529	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-12-15	2020-12-16	2,500	$52.16	$130.4K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-12-15	2020-12-16	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-11-16	2020-11-17	2,500	—	$0	160,029	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-11-16	2020-11-17	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-11-16	2020-11-17	2,500	$39.38	$98.5K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-10-15	2020-10-16	2,500	—	$0	162,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-10-15	2020-10-16	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-10-15	2020-10-16	2,500	$35.00	$87.5K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-10-07	2020-10-09	7,500	—	$0	165,029	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-10-07	2020-10-09	7,500	$2.67	$20.0K	677,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-10-07	2020-10-09	7,500	$35.00	$262.5K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-06-15	2020-06-16	2,500	—	$0	172,529	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-06-15	2020-06-16	2,500	$30.21	$75.5K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-06-15	2020-06-16	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-05-15	2020-05-19	2,500	—	$0	175,029	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-05-15	2020-05-19	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-05-15	2020-05-19	2,500	$30.00	$75.0K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-04-15	2020-04-17	2,500	—	$0	177,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-04-15	2020-04-17	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-04-15	2020-04-17	2,500	$30.00	$75.0K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-03-25	2020-03-26	2,500	—	$0	180,029	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-03-25	2020-03-26	2,500	$30.00	$75.0K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-03-25	2020-03-26	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-02-14	2020-02-19	2,500	—	$0	182,529	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-02-14	2020-02-19	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-02-14	2020-02-19	2,500	$42.35	$105.9K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise deriv	2020-01-15	2020-01-17	2,500	—	$0	185,029	SEC↗
APLS Apellis Pharmaceuticals, I	S Sale	2020-01-15	2020-01-17	2,500	$41.47	$103.7K	669,544	SEC↗
APLS Apellis Pharmaceuticals, I	M Exercise	2020-01-15	2020-01-17	2,500	$2.67	$6.7K	672,044	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2020-01-01	2020-01-03	27,600	$30.62	$845.1K	27,600	SEC↗
CREX CREATIVE REALITIES, INC.	A Award	2019-10-01	2019-10-03	3,634	—	$0	6,352	SEC↗
CREX CREATIVE REALITIES, INC.	A Award	2019-07-01	2019-07-03	2,718	—	$0	2,718	SEC↗
APLS Apellis Pharmaceuticals, I	A Award deriv	2019-01-01	2019-01-03	17,580	—	$0	17,580	SEC↗
APLS Apellis Pharmaceuticals, I	J Other	2018-05-07	2018-05-09	930	—	$0	930	SEC↗
APLS Apellis Pharmaceuticals, I	J Other	2018-05-07	2018-05-09	288,219	—	$0	669,544	SEC↗